Related references
Note: Only part of the references are listed.Perioperative circulating tumor DNA as a potential prognostic marker for operable stage I to IIIA non-small cell lung cancer
Ning Li et al.
CANCER (2022)
Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial
Cecile Le Pechoux et al.
LANCET ONCOLOGY (2022)
Prognostic index for estimating the survival benefit of postoperative radiotherapy in pathologic N2 non-small cell lung cancer: A real-world validation study
Chen-Chen Zhang et al.
LUNG CANCER (2021)
Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non-Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy The Phase 3 PORT-C Randomized Clinical Trial
Zhouguang Hui et al.
JAMA ONCOLOGY (2021)
Long-term outcomes of upfront surgery in patients with resectable pathological N2 non-small-cell lung cancer
Jae Kwang Yun et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2020)
Optimal adjuvant therapy in clinically N2 non-small cell lung cancer patients undergoing neoadjuvant chemotherapy and surgery: The importance of pathological response and lymph node ratio
Ashwin Shinde et al.
LUNG CANCER (2019)
Upfront surgery as first-line therapy in selected patients with stage IIIA non-small cell lung cancer
Difan Zheng et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2018)
A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery
Qixing Mao et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2018)
Survival Patterns for Patients with Resected N2 Non-Small Cell Lung Cancer and Postoperative Radiotherapy: A Prognostic Scoring Model and Heat Map Approach
Weiye Deng et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non-Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database
Alex Herskovic et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Management of stage III non-small cell lung cancer
Samer Tabchi et al.
SEMINARS IN ONCOLOGY (2017)
Long-term outcomes after lobectomy for non small cell lung cancer when unsuspected pN2 disease is found: A National Cancer Data Base analysis
Chi-Fu Jeffrey Yang et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2016)
The Clinical Impact of Solid and Micropapillary Patterns in Resected Lung Adenocarcinoma
Naoki Yanagawa et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Postoperative Radiotherapy for Pathologic N2 Non-Small-Cell Lung Cancer Treated With Adjuvant Chemotherapy: A Review of the National Cancer Data Base
Cliff G. Robinson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence Survival
Hideki Ujiie et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Re-evaluation of the Role of Postoperative Radiotherapy and the Impact of Radiation Dose for Non-Small-Cell Lung Cancer Using the National Cancer Database
Christopher D. Corso et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Role of Postoperative Radiotherapy After Curative Resection and Adjuvant Chemotherapy for Patients With Pathological Stage N2 Non-Small-Cell Lung Cancer: A Propensity Score Matching Analysis
Byoung Hyuck Kim et al.
CLINICAL LUNG CANCER (2014)
The IASLC Lung Cancer Staging Project: The New Database to Inform the Eighth Edition of the TNM Classification of Lung Cancer
Ramon Rami-Porta et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Evidence supporting contemporary post-operative radiation therapy (PORT) using linear accelerators in N2 lung cancer
Suchit H. Patel et al.
LUNG CANCER (2014)
Comparison of efficacy for postoperative chemotherapy and concurrent radiochemotherapy in patients with IIIA-pN2 non-small cell lung cancer: An early closed randomized controlled trial
Wen-yi Shen et al.
RADIOTHERAPY AND ONCOLOGY (2014)
Lymph Node Ratio May Predict the Benefit of Postoperative Radiotherapy in Non-Small-Cell Lung Cancer
Damien Urban et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
The Novel Histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification System of Lung Adenocarcinoma Is a Stage-Independent Predictor of Survival
Arne Warth et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Number of Circulating Endothelial Progenitor Cells and Intratumoral Microvessel Density in Non-small Cell Lung Cancer Patients Differences in Angiogenic Status between Adenocarcinoma Histologic Subtypes
Ryo Maeda et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non-Small-Cell Lung Cancer
Matthew G. Krebs et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
A MULTICENTER RETROSPECTIVE ANALYSIS OF SURVIVAL OUTCOME FOLLOWING POSTOPERATIVE CHEMORADIOTHERAPY IN NON-SMALL-CELL LUNG CANCER PATIENTS WITH N2 NODAL DISEASE
Bingwen Zou et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Postoperative radiotherapy for stage II or III non-small-cell lung cancer using th surveillance, epidemiology, and end results database
Brian E. Lally et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Complete resection in lung cancer surgery: proposed definition
R Rami-Porta et al.
LUNG CANCER (2005)
Micropapillary component in lung adenocarcinoma - A distinctive histologic feature with possible prognostic significance
MB Amin et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2002)
Share Paper
